表紙
市場調查報告書

下一代隱形眼鏡、視覺補綴 (人工視覺)的全球市場:2019年∼2030年

Next Generation Contact Lenses and Visual Prostheses Market, 2019-2030

出版商 ROOTS ANALYSIS 商品編碼 791882
出版日期 內容資訊 英文 230 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
下一代隱形眼鏡、視覺補綴 (人工視覺)的全球市場:2019年∼2030年 Next Generation Contact Lenses and Visual Prostheses Market, 2019-2030
出版日期: 2019年02月28日內容資訊: 英文 230 Pages
簡介

根據美國的國立眼科疾病研究所 (NEI) ,失明者數約130萬人,弱視者數290萬人。預計美國至2030年失明者數將增加到220萬人,弱視者數到500萬人。

本報告提供下一代隱形眼鏡、視覺補綴 (人工視覺) 市場相關調查分析,市場形勢,技術形勢,專利分析,市場預測等相關的系統性資訊。

第1章 序文

第2章 摘要整理

第3章 簡介

第4章 市場概要

  • 概要
  • 下一代隱形眼鏡:綜合市場形勢
  • 下一代隱形眼鏡:治療用鏡片的市場形勢
  • 下一代隱形眼鏡:藥物釋放型鏡片的市場形勢
  • 下一代隱形眼鏡:診斷/監測用鏡片的市場形勢
  • 視覺補綴:綜合市場形勢
  • 相關利益者企業、KOL的地理分佈

第5章 促銷分析

  • 概要
  • 流通管道概要
  • 引進流通管道
  • ChromaGen
  • CUSTOMFLEX
  • EYEMATE
  • Hyper-CL
  • 移植式超小型望遠鏡 (IMT)
  • SENSIMED Triggerfish

第6章 技術簡介

  • 概要
  • 下一代隱形眼鏡:新興技術
  • EyePrintPRO
  • Leo Lens Technology
  • Nanowafer Technology
  • The Diamond Eye Technology

第7章 專利分析

  • 概要
  • 調查範圍、手法
  • 下一代隱形眼鏡、視覺補綴:專利分析
  • 下一代隱形眼鏡、視覺補綴:專利基準分析
  • 下一代隱形眼鏡、視覺補綴:專利評估分析

第8章 夥伴關係、聯盟

  • 概要
  • 夥伴關係模式
  • 下一代隱形眼鏡、視覺補綴:夥伴關係、聯盟的清單

第9章 對社群媒體的新興趨勢

  • 概要
  • 下一代隱形眼鏡、視覺補綴:Twitter趨勢

第10章 KOL分析

第11章 市場規模與預測

  • 概要
  • 預測手法
  • 下一代隱形眼鏡、視覺補綴綜合市場
  • 北美的下一代隱形眼鏡、視覺補綴市場
  • EU5個國家的下一代隱形眼鏡、視覺補綴市場
  • 亞太地區的下一代隱形眼鏡、視覺補綴市場

第12章 採訪

  • 概要
  • EyeYon Medical
  • OcuMedic
  • Leo Lens Technology

第13章 結論

第14章 附錄1

第15章 附錄2

目錄
Product Code: RA100127

Example Insights

Partnership activity across the globe is indicative of the increasing interest of stakeholders in developing novel products for use in treating ophthalmic disorders.

Overview

For more than five decades, contact lenses have primarily been used to correct vision-related disorders. The existence of several unmet needs in the field of ophthalmology, recent technological advances and the availability of new biomaterials, have substantially expanded the range of potential application areas for contact lenses. It is estimated that close to 2.4 million eye injuries occur every year in the US. In order to cater to this demand, a myriad of therapeutic contact lenses have been developed specifically for treating / protecting the eye. The efficient delivery of drugs / other therapeutic substances to the eye is also deemed to be an area for improvement. It is presently characterized by low bioavailability and limited exposure time to pharmacological interventions; for instance, in the case of eye drops, 95% of the active therapeutic ingredient is assumed to be lost / wasted post dose administration. A variety of drug-eluting contact lenses have been / are being developed to address the aforementioned challenges. The potential of contact lenses is being explored for diagnosis and disease monitoring purposes as well. Diabetes and glaucoma are key clinical conditions for which contact lenses are being developed to assess and track various disease related parameters. In fact, 10 contact lenses have already been approved for purposes other than vision correction; recent examples include CUSTOMFLEX® ARTIFICIALIRIS (aniridia, 2018) and EYEMATE® (glaucoma, 2017).

On the other hand, according to the National Eye Institute, nearly 1.3 million people are blind, while 2.9 million individuals have poor vision, in the US. It is estimated that the number of cases for blindness and poor vision are likely to reach 2.2 million and 5 million, respectively, by 2030, in the same region. Visual prosthetics, such as bionic eyes, represent the next generation of solutions for vision restoration. Their unique mechanism of action leverages electrical pulses to stimulate optic nerves and bypass damaged segments of region in the eye. Pharmaceutical companies and academic institutions have already invested a significant amount of capital in the development and commercialization of the abovementioned products. The ongoing efforts to innovate in this domain are evident from the fact that more than 7,500 patents have been granted / filed since 2013. In the coming years, the market is anticipated to grow at a significant pace as more novel solutions clear clinical evaluation and get commercialized.

Scope of the Report

The ‘Next Generation Contact Lenses and Visual Prostheses Market, 2019-2030’ report features an extensive study of the current market landscape of therapeutic contact lenses, drug-eluting contact lenses, diagnostic / monitoring contact lenses and visual prostheses. The study lays emphasis on the novel products and technologies that are being developed for the treatment of ocular disorders, which generally cause severe visual impairment or blindness. Amongst other elements, the report includes:

  • A detailed review of the landscape of novel ophthalmic products, highlighting the different categories of contact lenses and visual prostheses (bionic eye technologies) developed / being developed by various players across the world. It features information on the purpose of development (therapeutic, drug delivery, and diagnosis / monitoring), current development status, target indication(s), type of product, type of organization (industry or non-industry) and location of company headquarters.
  • An analysis of the key promotional strategies that have been adopted by the developers of marketed products, namely ChromaGen™, CUSTOMFLEX® ARTIFICIALIRIS, EYEMATE®, Hyper-CL™, Implantable Miniature Telescope and SENSIMED Triggerfish®.
  • Brief profiles of the novel technologies that are being developed to expand the functionality of contact lenses; each profile features an overview of the technology, along with details on its working mechanism, information on application areas, type of products, key benefits, technical specifications and important details related to the developer company.
  • An in-depth analysis of the various patents granted / filed related to next generation contact lenses and visual prostheses since 2013, highlighting the prevalent and emerging related to the innovation in this domain. The analysis takes into consideration the type of patent, regional applicability, CPC classification, emerging focus areas, leading industry / non-industry players (in terms of the number of patents filed / granted), and patent valuation.
  • An analysis of the partnerships that have been established in this domain, covering R&D agreements, product development agreements, product commercialization agreements, service alliance and acquisitions; the analysis is based on multiple parameters, such as the type of agreement, type of organization, and focus area in terms of product application and target indication.
  • A study of prevalent and emerging trends, and the popularity of next generation contact lenses and visual prostheses, as observed on the social media platform, Twitter. The analysis takes into consideration the tweets posted on the platform, between 2013 and 2018 (till mid-October).
  • A list of key opinion leaders (KOLs) in this domain, featuring a 2X2 analysis to assess the relative experience of certain individuals, who were shortlisted based on their contributions (in terms of involvement in various clinical studies) to this field. It includes a schematic world map representation, highlighting the geographical locations of eminent scientists / researchers engaged in this domain. In addition, it presents an analysis assessing the credibility and (relative) level of expertise of different KOLs based on number of publications, number of citations, number of clinical trials, number of affiliations and extent of professional network.

One of the key objectives of the report was to determine the existing market size and develop estimates of future growth opportunities for next generation contact lenses and visual prostheses. Based on parameters, such as the target patient population, price of the lenses and the likely adoption rates, we have provided an informed estimate on the likely evolution of the market over the period 2019-2030. The report also features a detailed segmentation of the present and anticipated future opportunity based on [A] type of product (contact lenses and visual prostheses) [B] purpose of development of contact lenses (therapeutic, drug delivery and diagnosis / monitoring) [C] key disease indications (glaucoma, diabetes, AMD, retinitis pigmentosa and others) and [D] geography (North America, EU5 and Asia-Pacific). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely the conservative, base and optimistic scenarios, which represent different tracks of the industry's evolution.

The opinions and insights presented in this study were also influenced by discussions conducted with several stakeholders in this domain. The report features detailed transcripts of interviews held with Mark E Byrne (Co-Founder and Chief Technical Officer, OcuMedic), Michal Shavit (Head of Sales and Marketing, EyeYon Medical and Praful Doshi (Founder, Chief Executive Officer and Chief Technical Officer, Leo Lens Technology).

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Chapter Outlines

Chapter 2 is an executive summary of the insights captured in our research. The summary offers a high-level view on the likely evolution of next generation contact lenses and visual prostheses market in the short term, mid term and long term.

Chapter 3 provides a general introduction to next generation ophthalmic lenses, highlighting the general concept of contact lenses along with the different types / classes of such products, along with their respective application areas. Further, it provides an overview of visual prostheses, describing the architecture and applications of such products. It also features a brief discussion on key therapeutic areas and the future of contact lenses.

Chapter 4 features a list of novel contact lenses that are developed / being developed for -therapeutic, drug delivery and diagnosis / monitoring purposes by both industry and non-industry players. It includes a list of visual prostheses that are either marketed or being developed by various companies. The chapter includes a detailed analysis of the aforementioned products based on various parameters, such as status of development, type of developer organization, location of headquarters (of the developer), target indication and type of product.

Chapter 5 highlights the key promotional strategies that are being implemented by the developers of marketed products, including ChromaGen™, CUSTOMFLEX® ARTIFICIALIRIS, EYEMATE®, Hyper-CL™, Implantable Miniature Telescope and SENSIMED Triggerfish®. The promotional aspects covered in the chapter include details that are provided on the product website (covering key messages for patients and healthcare professionals), patient support offerings and informative downloadable content.

Chapter 6 features brief profiles of novel technologies being developed by various industry, as well as non-industry players. Each profile presents an overview of the developer, key features of the technology, details on its working mechanism, and information on the area of application, type of product and advantages offered by the technology.

Chapter 7 provides an in-depth patent analysis, presenting an overview on the filed / granted patents related to next generation contact lenses and visual prostheses. For this analysis, we looked at the patents that have been published by various players since 2013. The analysis highlights the key information and trends associated with these patents, including patent type (granted patents, patent applications and others), patent publication year, regional distribution, CPC classification, emerging areas and leading industry / non-industry players. The chapter also includes a patent benchmarking and valuation analysis.

Chapter 8 features an analysis and discussion of the various collaborations and partnerships that have been inked amongst the players in this domain. It includes a brief description on the various types of partnership models (including product development agreements, product commercialization agreements, R&D agreements, service alliance and acquisitions) that have been adopted by stakeholders in this domain. The analysis highlights the prevailing trends with respect to the type of partnership, type of organization, and focus area in terms of product application and target indication. Furthermore, the chapter includes a world map representation of all the deals inked in this field, highlighting both intercontinental and intracontinental partnership activity.

Chapter 9 provides insights on the popularity of next generation contact lenses and visual prostheses on the social media platform, Twitter. For this analysis, we have analyzed tweets posted on the platform in the period between January 2013 and mid-October 2018. The chapter showcases the most frequently mentioned keywords / phrases and a bubble analysis of the most prolific and most influential authors, related to next generation contact lenses and visual prostheses, on Twitter.

Chapter 10 provides an analysis of KOLs in the field of next generation contact lenses and visual prostheses. It features a comprehensive list of principal investigators / study directors of different clinical trials, along with the information related to the affiliated research institutes. The chapter features a schematic representation on a world map, highlighting the geographical locations of eminent scientists / researchers who are engaged in clinical research in this domain. It also presents a comparative analysis, highlighting those KOLs who have relatively more experience in this domain. The credibility and (relative) level of expertise of different KOLs defined by other analysts / industry experts were compared to the results obtained using a proprietary scoring criteria, which was based on number of publications, number of citations, number of clinical trials, number of affiliations and extent of network.

Chapter 11 presents a comprehensive market forecast analysis, highlighting the future potential of next generation contact lenses and visual prostheses, till the year 2030. We have provided inputs on the likely opportunity on the basis of type of product (contact lenses and visual prostheses, purpose of development of contact lenses (therapeutic, drug delivery and diagnostic / monitoring), various target indications (glaucoma, diabetes, AMD, retinitis pigmentosa and others) and different regions (North America, EU5 and Asia-Pacific).

Chapter 12 summarizes the entire report. It presents a list of key takeaways and offers our independent opinion on the current market scenario. Further, it captures the evolutionary trends that are likely to determine the future of this segment of the industry.

Chapter 13 is a collection of interview transcripts of the discussions held with key stakeholders in the industry. In this chapter, we have presented the details of interviews held with Mark E. Byrne (Co-Founder and Chief Technical Officer, OcuMedic), Michal Shavit (Head of Sales and Marketing, EyeYon Medical) and Praful Doshi (Founder, Chief Executive Officer and Chief Technical Officer, Leo Lens Technology).

Chapter 14 is an appendix, which provides tabulated data and numbers for all the figures included in the report.

Chapter 15 is an appendix, which contains the list of companies and organizations that have been mentioned in the report.

Table of Contents

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
  • 1.3. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Context and Background
  • 3.2. An Overview of Contact Lenses
    • 3.2.1. Evolution of Contact Lenses
    • 3.2.2. Applications of Contact Lenses
    • 3.2.3. Types of Contact Lenses
    • 3.2.4. Classification of Contact Lenses
      • 3.2.4.1. Therapeutic Contact Lenses
      • 3.2.4.2. Drug-Eluting Contact Lenses
        • 3.2.4.2.1. Mechanism of Drug Delivery through Contact Lenses
        • 3.2.4.2.2. Techniques for Developing Drug-Eluting Contact Lenses
      • 3.2.4.3. Diagnostic / Monitoring Contact Lenses
        • 3.2.4.3.1. Working of Diagnostic / Monitoring Contact Lenses
  • 3.4. Visual Prostheses
    • 3.4.1. Architecture of a Bionic Eye
    • 3.4.2. Working of a Bionic Eye
  • 3.5. Key Therapeutic Indications
  • 3.6. Prevalent Trends and Future Perspectives

4. MARKET OVERVIEW

  • 4.1. Chapter Overview
  • 4.2. Next Generation Contact Lenses: Overall Market Landscape
    • 4.2.1. Distribution by Type of Developer
    • 4.2.2. Distribution by Location of Headquarters of Developers
    • 4.2.3. Distribution by Status of Development
    • 4.2.4. Distribution by Target Indication
    • 4.2.5. Distribution by Type of Product
  • 4.3. Next Generation Contact Lenses: Market Landscape of Therapeutic Lenses
  • 4.4. Next Generation Contact Lenses: Market Landscape of Drug-Eluting Lenses
  • 4.5. Next Generation Contact Lenses: Market Landscape of Diagnostic / Monitoring Lenses
  • 4.6. Visual Prostheses: Overall Market Landscape
    • 4.6.1. Distribution by Type of Developer
    • 4.6.2. Distribution by Location of Headquarters of Developers
    • 4.6.3. Distribution by Status of Development
    • 4.6.4. Distribution by Target Indication
    • 4.6.5. Distribution by Implant Site
  • 4.7 Geographical Distribution of Stakeholder Players and KOLs

5. PROMOTIONAL ANALYSIS

  • 5.1. Chapter Overview
  • 5.2. An Overview of Channels Used for Promotional Campaigns
  • 5.3. Channels Adopted by Industry Players for Promotional Campaigns
    • 5.3.1. Product Website Analysis
    • 5.3.2. Product Brochure Analysis
    • 5.3.3. Product User Manual Analysis
  • 5.4. ChromaGen™: Promotional Analysis
    • 5.4.1. Product Overview
    • 5.4.2. Product Website / Brochure Analysis
      • 5.4.2.1. Messages for Healthcare Professionals
      • 5.4.2.2. Messages for Patients
  • 5.5. CUSTOMFLEX® ARTIFICIALIRIS: Promotional Analysis
    • 5.5.1. Product Overview
    • 5.5.2. Product Website / Brochure Analysis
      • 5.5.2.1. Messages for Healthcare Professionals
      • 5.5.2.2. Messages for Patients
      • 5.5.2.3. Other Messages
    • 5.5.3. Other Promotional Activities
      • 5.5.3.1. Publication in Journals
  • 5.6. EYEMATE®: Promotional Analysis
    • 5.6.1. Product Overview
    • 5.6.2. Product Website / Brochure Analysis
      • 5.6.2.1. Messages for Healthcare Professionals
      • 5.6.2.2. Messages for Patients
    • 5.6.3. Other Promotional Activities
      • 5.6.3.1. Publication in Journals
  • 5.7. Hyper-CL™: Promotional Analysis
    • 5.7.1. Product Overview
    • 5.7.2. Product Website / Brochure Analysis
      • 5.7.2.1. Messages for Healthcare Professionals
      • 5.7.2.2. Messages for Patients
    • 5.7.3. Product User Manual Analysis
      • 5.7.3.1. Other Messages
    • 5.7.4. Other Promotional Activities
      • 5.7.4.1. Publication in Journals
  • 5.8. Implantable Miniature Telescope: Promotional Analysis
    • 5.8.1. Product Overview
    • 5.8.2. Product Website / Brochure Analysis
      • 5.8.2.1. Messages for Healthcare Professionals
      • 5.8.2.2. Patient Access Program
      • 5.8.2.3. Other Messages
    • 5.8.3. Product User Manual Analysis
      • 5.8.3.1. Messages for Patients
    • 5.8.4. Other Promotional Activities
      • 5.8.4.1. Publication in Journals
  • 5.9. SENSIMED Triggerfish®: Promotional Analysis
    • 5.9.1. Product Overview
    • 5.9.2. Product Website / Brochure Analysis
      • 5.9.2.1. Messages for Healthcare Professionals
      • 5.9.2.2. Messages for Patients
    • 5.9.3. Product User Manual Analysis
      • 5.9.3.1. Other Messages
    • 5.9.4. Other Promotional Activities
      • 5.9.4.1. Publication in Journals
      • 5.9.4.2. Presence in Conferences

6. TECHNOLOGY PROFILES

  • 6.1. Chapter Overview
  • 6.2. Next Generation Contact Lenses: Novel Technologies
  • 6.3. EyePrintPRO™
    • 6.3.1. Developer Overview
    • 6.3.2. Technology Overview
      • 6.3.2.1. Working Mechanism
  • 6.4. Interscatter Communication Technology
    • 6.4.1. Developer Overview
    • 6.4.2. Technology Overview
      • 6.4.2.1. Working Mechanism
  • 6.5. Leo Lens Technology
    • 6.5.1. Developer Overview
    • 6.5.2. Technology Overview
      • 6.5.2.1. Working Mechanism
  • 6.6. Nanowafer Technology
    • 6.6.1. Developer Overview
    • 6.6.2. Technology Overview
      • 6.6.2.1. Working Mechanism
  • 6.7. The Diamond Eye™ Technology
    • 6.7.1. Developer Overview
    • 6.7.2. Technology Overview
      • 6.7.2.1. Working Mechanism

7. PATENT ANALYSIS

  • 7.1. Chapter Overview
  • 7.2. Scope and Methodology
  • 7.3. Next Generation Contact Lenses and Visual Prostheses: Patent Analysis
    • 7.3.1. Analysis by Publication Year
    • 7.3.2. Analysis by Geographical Location
    • 7.3.3. Analysis by CPC Classification
    • 7.3.4. Emerging Focus Areas
    • 7.3.5. Leading Industry Players by Number of Patents
    • 7.3.6. Leading Non-Industry Players by Number of Patents
  • 7.4. Next Generation Contact Lenses and Visual Prostheses: Patent Benchmarking Analysis (Industry Players)
    • 7.4.1. Analysis by CPC Classification
    • 7.4.2. Analysis by Geography
  • 7.5. Next Generation Contact Lenses and Visual Prostheses: Patent Benchmarking Analysis (Non-Industry Players)
    • 7.5.1. Analysis by CPC Classification
    • 7.5.2. Analysis by Geography
  • 7.6. Next Generation Contact Lenses and Visual Prostheses: Patent Valuation Analysis

8. PARTNERSHIPS AND COLLABORATIONS

  • 8.1. Chapter Overview
  • 8.2. Partnership Models
  • 8.3. Next Generation Contact Lenses and Visual Prostheses: List of Partnerships and Collaborations
    • 8.3.1. Analysis by Type of Partnership
    • 8.3.2. Analysis by Type of Organization
    • 8.3.3. Analysis by Area of Application
    • 8.3.4. Analysis by Target Indication
    • 8.3.5. Regional Analysis
      • 8.3.5.1. Intercontinental and Intracontinental Agreements

9. EMERGING TRENDS ON SOCIAL MEDIA

  • 9.1. Chapter Overview
  • 9.2. Next Generation Contact Lenses and Visual Prostheses: Trends on Twitter
    • 9.2.1. Social Media Analysis: Trending Words / Phrases Related to Next Generation Contact Lenses and Visual Prostheses on Twitter
    • 9.2.2. Social Media Analysis: Most Prolific Authors on Twitter

10. KOL ANALYSIS

  • 10.1. Chapter Overview
  • 10.2. Methodology
  • 10.3. Principal Investigators / Sub-Investigators / Study Directors Involved in Clinical Trials
    • 10.3.1. Geographical Distribution
  • 10.4. Prominent Key Opinion Leaders
  • 10.5. KOL Benchmarking: Roots Analysis versus Third Party Scoring
  • 10.6. Prominent Key Opinion Leaders
    • 10.6.1. Profile: KOL A (Wills Eye Hospital)
    • 10.6.2. Profile: KOL B (Retina Foundation of the Southwest)
    • 10.6.3. Profile: KOL C (Rabin Medical Center)
    • 10.6.4. Profile: KOL D (University of Oxford)
    • 10.6.5. Profile: KOL E (New York Eye and Ear Infirmary)
    • 10.6.6. Profile: KOL F (Fred Hutchinson Cancer Research Center)

11. MARKET SIZING AND FORECAST

  • 11.1. Chapter Overview
  • 11.2. Forecast Methodology
  • 11.3. Overall Next Generation Contact Lenses and Visual Prostheses Market, 2019-2030
    • 11.3.1. Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Type of Product, 2019-2030
      • 11.3.1.1. Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Type of Lenses, 2019-2030
    • 11.3.2. Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Type of Indications, 2019-2030
    • 11.3.3. Next Generation Contact Lenses and Visual Prostheses Market: Regional Distribution, 2019-2030
  • 11.4. Next Generation Contact Lenses and Visual Prostheses Market in North America, 2019-2030
    • 11.4.1. Next Generation Contact Lenses and Visual Prostheses Market in North America: Distribution by Type of Product, 2019-2030
      • 11.4.1.1. Next Generation Contact Lenses and Visual Prostheses Market in North America: Contact Lenses, 2019-2030
        • 11.4.1.1.1. Next Generation Contact Lenses and Visual Prostheses Market in North America: Therapeutic Lenses, 2019-2030
        • 11.4.1.1.2. Next Generation Contact Lenses and Visual Prostheses Market in North America: Drug-Eluting Lenses, 2019-2030
        • 11.4.1.1.3. Next Generation Contact Lenses and Visual Prostheses Market in North America: Diagnostic / Monitoring Lenses, 2019-2030
      • 11.4.1.2. Next Generation Contact Lenses and Visual Prostheses Market in North America: Visual Prostheses, 2019-2030
    • 11.4.2. Next Generation Contact Lenses and Visual Prostheses Market in North America: Distribution by Indication, 2019-2030
      • 11.4.2.1. Next Generation Contact Lenses and Visual Prostheses Market in North America: Diabetes, 2019-2030
      • 11.4.2.2. Next Generation Contact Lenses and Visual Prostheses Market in North America: Glaucoma, 2019-2030
      • 11.4.2.3. Next Generation Contact Lenses and Visual Prostheses Market in North America: Age-associated Macular Degeneration, 2019-2030
      • 11.4.2.4. Next Generation Contact Lenses and Visual Prostheses Market in North America: Retinitis Pigmentosa, 2019-2030
      • 11.4.2.5. Next Generation Contact Lenses and Visual Prostheses Market in North America: Corneal Problems and Post-Surgical Complications, 2019-2030
      • 11.4.2.6. Next Generation Contact Lenses and Visual Prostheses Market in North America: Other Indications, 2019-2030
  • 11.5. Next Generation Contact Lenses and Visual Prostheses Market in EU5, 2019-2030
    • 11.5.1. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Distribution by Type of Product, 2019-2030
      • 11.5.1.1. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Contact Lenses, 2019-2030
        • 11.5.2.1.1. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Therapeutic Lenses, 2019-2030
        • 11.5.1.1.2. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Drug-Eluting Lenses, 2019-2030
        • 11.5.1.1.3. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Diagnostic / Monitoring Lenses, 2019-2030
      • 11.5.1.2. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Visual Prostheses, 2019-2030
    • 11.5.2. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Distribution by Indication, 2019-2030
      • 11.5.2.1. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Diabetes, 2019-2030
      • 11.5.2.2. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Glaucoma, 2019-2030
      • 11.5.2.3. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Age-associated Macular Degeneration, 2019-2030
      • 11.5.2.4. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Retinitis Pigmentosa, 2019-2030
      • 11.5.2.5. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Corneal Problems and Post-Surgical Complications, 2019-2030
      • 11.5.2.6. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Other Indications, 2019-2030
  • 11.6. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific, 2019-2030
    • 11.6.1. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Distribution by Type of Product, 2019-2030
      • 11.6.1.1. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Contact Lenses, 2019-2030
        • 11.6.1.1.1. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Therapeutic Lenses, 2019-2030
        • 11.6.1.1.2. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Drug-Eluting Lenses, 2019-2030
        • 11.6.1.1.3. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Diagnostic / Monitoring Lenses, 2019-2030
      • 11.6.1.2. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Visual Prostheses, 2019-2030
    • 11.6.2. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Distribution by Indication, 2019-2030
      • 11.6.2.1. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Diabetes, 2019-2030
      • 11.6.2.2. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Glaucoma, 2019-2030
      • 11.6.2.3. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Age-associated Macular Degeneration, 2019-2030
      • 11.6.2.4. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Retinitis Pigmentosa, 2019-2030
      • 11.6.2.5. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Corneal Problems and Post-Surgical Complications, 2019-2030
      • 11.6.2.6. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Other Indications, 2019-2030

12. INTERVIEW TRANSCRIPTS

  • 12.1. Chapter Overview
  • 12.2. EyeYon Medical
    • 12.2.1. Interview Transcript: Michal Shavit, Head of Sales and Marketing
  • 12.3. OcuMedic
    • 12.3.1. Interview Transcript: Mark E. Byrne, Co-Founder and Chief Technical Officer
  • 12.4. Leo Lens Technology
    • 12.4.1. Interview Transcript: Praful Doshi, Founder, Chief Executive Officer and Chief Technical Officer

13. CONCLUSION

  • 13.1. Advances in Ophthalmic Lens Technologies have Enabled the Development of Contact Lenses for Therapeutic, Bandage and Diagnostic Use
  • 13.2. The Competitive Landscape Features a Mix of Industry and Academic Players; Majority of Stakeholder are based in the US
  • 13.3. Rising Interest in this Domain is Evident from Increasing Social Media Chatter and the Partnership Activity
  • 13.4. Technology Developers are Spearheading the Innovation, and Making Substantial Contributions to the Intellectual Capital in this Field
  • 13.5. Driven by Anticipated Growth in Target Population, Coupled to the Ongoing Innovation, the Market is Likely to Witness Steady Growth over the Next Decade

14. APPENDIX 1: TABULATED DATA

15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Figures

  • Figure 3.1: Historical Evolution of Contact Lenses
  • Figure 3.2: Advantages and Disadvantages of Different Types of Contact Lenses
  • Figure 3.3: Applications of Bandage Contact Lenses
  • Figure 3.4: Barriers to Ocular Drug Delivery
  • Figure 3.5: Novel Approaches for Corneal Drug Delivery
  • Figure 3.6: Steps Involved in Molecular Imprinting
  • Figure 3.7: Diagnostic / Monitoring Contact Lenses: Steps of Operations
  • Figure 3.8: Visual Prostheses: External and Implantable Modules
  • Figure 3.9: Visual Prostheses: Mode of Operation
  • Figure 3.10: Key Therapeutic Indications Targeting Contact Lenses and Visual Prostheses
  • Figure 4.1: Next Generation Contact Lenses: Distribution by Type of Developer
  • Figure 4.2: Next Generation Contact Lenses: Distribution by Type of Developer and Type of Contact Lenses
  • Figure 4.3: Next Generation Contact Lenses: Distribution by Location of Headquarters of Developer
  • Figure 4.4: Next Generation Contact Lenses: Distribution by Location of Headquarters of Developer and Type of Contact Lenses
  • Figure 4.5: Next Generation Contact Lenses: Distribution by Status of Development
  • Figure 4.6: Next Generation Contact Lenses: Distribution by Status of Development and Type of Contact Lenses
  • Figure 4.7: Next Generation Contact Lenses: Distribution by Target Indication
  • Figure 4.8: Next Generation Contact Lenses: Distribution by Target Indication and Type of Contact Lenses
  • Figure 4.9: Next Generation Contact Lenses: Distribution by Type of Product
  • Figure 4.10: Visual Prostheses: Distribution by Type of Developer
  • Figure 4.11: Visual Prostheses: Distribution by Location of Headquarters of Developer
  • Figure 4.12: Visual Prostheses: Distribution by Status of Development
  • Figure 4.13: Visual Prostheses: Distribution by Target Indication
  • Figure 4.14: Visual Prostheses: Distribution by Implant Site
  • Figure 4.15: Visual Prostheses: Logo Landscape of Bionic Eye Developers based on Implant Site
  • Figure 4.16: Next Generation Contact Lenses and Visual Prostheses: Geographical Distribution of Stakeholder Players and KOLs
  • Figure 5.1: Promotional Strategy: Channels Adopted for Promotional Campaigns
  • Figure 5.2: Promotional Strategy: Product Website Analysis
  • Figure 5.3: Promotional Strategy: Product Brochure Analysis
  • Figure 5.4: Promotional Strategy: Product User Manual Analysis
  • Figure 5.5: ChromaGen™ Product Website Analysis: Messages for Healthcare Professionals
  • Figure 5.6: ChromaGen™ Product Website Analysis: Messages for Patients
  • Figure 5.7: CUSTOMFLEX® ARTIFICIALIRIS Product Brochure Analysis: Warnings and Precautions
  • Figure 5.8: CUSTOMFLEX® ARTIFICIALIRIS Product Website Analysis: Messages for Patients
  • Figure 5.9: CUSTOMFLEX® ARTIFICIALIRIS Product Brochure Analysis: Other Messages
  • Figure 5.10: EYEMATE® Product Website Analysis: Messages for Healthcare Professionals
  • Figure 5.11: EYEMATE® Product Website Analysis: Key Advantages
  • Figure 5.12: Hyper-CL™ Product Brochure Analysis: Messages for Healthcare Professionals
  • Figure 5.13: Hyper-CL™ Product Brochure Analysis: Messages for Healthcare Professionals, Comparative Study Results
  • Figure 5.14: Hyper-CL™ Product Website Analysis: Messages for Patients
  • Figure 5.15: Hyper-CL™ Product User Manual Analysis: Warnings and Precautions
  • Figure 5.16: Hyper-CL™ Product User Manual Analysis: General Instructions and Lens Handling Information
  • Figure 5.17: Implantable Miniature Telescope Product Brochure Analysis: Messages for Healthcare Professionals
  • Figure 5.18: Implantable Miniature Telescope Product Brochure Analysis: Reimbursement Information
  • Figure 5.19: Implantable Miniature Telescope Product Brochure Analysis: Other Messages
  • Figure 5.20: Implantable Miniature Telescope Product User Manual Analysis: Messages for Patients
  • Figure 5.21: SENSIMED Triggerfish® Product Website Analysis: Key Advantages
  • Figure 5.22: SENSIMED Triggerfish® Product Website Analysis: Messages for Healthcare Professionals
  • Figure 5.23: SENSIMED Triggerfish® Product Brochure Analysis: Data Visualization and Interpretation Information
  • Figure 5.24: SENSIMED Triggerfish® Product Website Analysis: Messages for Patients
  • Figure 5.25: SENSIMED Triggerfish® Product User Manual Analysis: Warnings and Precautions
  • Figure 5.26: SENSIMED Triggerfish® Product User Manual Analysis: Other Messages
  • Figure 6.1: Leo Lens Technology: Components
  • Figure 7.1: Patent Analysis: Distribution by Type of Patent
  • Figure 7.2: Patent Analysis: Cumulative Distribution by Publication Year, 2013-2018
  • Figure 7.3: Patent Analysis: Distribution by Geography
  • Figure 7.4: Patent Analysis: Distribution by CPC Classification
  • Figure 7.5: Patent Analysis: Emerging Focus Areas
  • Figure 7.6: Patent Analysis: Leading Industry Players
  • Figure 7.7: Patent Analysis: Leading Non-Industry Players
  • Figure 7.8: Patent Analysis (Industry Players): Number of Patents across Different Geographies
  • Figure 7.9: Patent Analysis (Industry Players): Benchmarking by International Patents
  • Figure 7.10: Patent Analysis (Non-Industry Players): Number of Patents across Different Geographies
  • Figure 7.11: Patent Analysis (Non-Industry Players): Benchmarking by International Patents
  • Figure 7.12: Patent Analysis: Distribution of Patents by Age (January 2013- Mid October 2018)
  • Figure 7.13: Patent Analysis: Valuation Analysis
  • Figure 8.1: Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 8.2: Partnerships and Collaborations: Distribution by Type of Organization
  • Figure 8.3: Partnerships and Collaborations: Distribution by Application Areas
  • Figure 8.4: Partnerships and Collaborations: Distribution by Target Indication
  • Figure 8.5: Partnerships and Collaborations: Regional Distribution
  • Figure 8.6: Partnerships and Collaborations: Intercontinental and Intracontinental Distribution
  • Figure 9.1: Social Media Analysis: Trending Words / Phrases on Twitter
  • Figure 9.2: Social Media Analysis: Trending Words / Phrases on Twitter Based on Focus Area
  • Figure 9.3: Social Media Analysis: Most Prolific Authors
  • Figure 9.4: Social Media Analysis: Bubble Chart Analysis Based on Average Likes, Re-tweets and Comments Related to Next Generation Contact Lenses and Visual Prostheses, on Twitter
  • Figure 10.1: KOL Analysis: Geographical Distribution of Principal Investigators / Sub-Investigators / Study Directors
  • Figure 10.2: KOL Analysis: Dot-Plot of Principal Investigators
  • Figure 10.3: KOL Benchmarking: Roots Analysis versus Third Party Scoring
  • Figure 10.4: KOL Benchmarking: Roots Analysis versus Third Party Scoring (Scatter Plot)
  • Figure 10.5: KOL Analysis: Most Prominent Key Opinion Leaders
  • Figure 11.1: Overall Next Generation Contact Lenses and Visual Prostheses Market, 2019-2030
  • Figure 11.2: Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Type of Product, 2019-2030
  • Figure 11.3: Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Type of Contact Lenses, 2019-2030
  • Figure 11.4: Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Type of Indications, 2019-2030
  • Figure 11.5: Next Generation Contact Lenses and Visual Prostheses Market: Regional Distribution, 2019-2030
  • Figure 11.6: Next Generation Contact Lenses and Visual Prostheses Market in North America, 2019-2030
  • Figure 11.7: Next Generation Contact Lenses and Visual Prostheses Market in North America: Distribution by Type of Product, 2019-2030
  • Figure 11.8: Next Generation Contact Lenses and Visual Prostheses Market in North America: Contact Lenses, 2019-2030
  • Figure 11.9: Next Generation Contact Lenses and Visual Prostheses Market in North America: Therapeutic Lenses, 2019-2030
  • Figure 11.10: Next Generation Contact Lenses and Visual Prostheses Market in North America: Drug-Eluting Lenses, 2019-2030
  • Figure 11.11: Next Generation Contact Lenses and Visual Prostheses Market in North America: Diagnostic / Monitoring Lenses, 2019-2030
  • Figure 11.12: Next Generation Contact Lenses and Visual Prostheses Market in North America: Visual Prostheses, 2019-2030
  • Figure 11.13: Next Generation Contact Lenses and Visual Prostheses Market in North America: Distribution by Indication, 2019-2030
  • Figure 11.14: Next Generation Contact Lenses and Visual Prostheses Market in North America: Diabetes, 2019-2030
  • Figure 11.15: Next Generation Contact Lenses and Visual Prostheses Market in North America: Glaucoma, 2019-2030
  • Figure 11.16: Next Generation Contact Lenses and Visual Prostheses Market in North America: Age-associated Macular Degeneration, 2019-2030
  • Figure 11.17: Next Generation Contact Lenses and Visual Prostheses Market in North America; Retinitis Pigmentosa, 2019-2030
  • Figure 11.18: Next Generation Contact Lenses and Visual Prostheses Market in North America: Corneal Problems and Post-Surgical Complications, 2019-2030
  • Figure 11.19: Next Generation Contact Lenses and Visual Prostheses Market in North America: Others, 2019-2030
  • Figure 11.20: Next Generation Contact Lenses and Visual Prostheses Market in EU5, 2019-2030
  • Figure 11.21: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Distribution by Type of Product, 2019-2030
  • Figure 11.22: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Contact Lenses, 2019-2030
  • Figure 11.23: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Therapeutic Lenses, 2019-2030
  • Figure 11.24: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Drug-Eluting Lenses, 2019-2030
  • Figure 11.25: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Diagnostic / Monitoring Lenses, 2019-2030
  • Figure 11.26: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Visual Prostheses, 2019-2030
  • Figure 11.27: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Distribution by Indication, 2019-2030
  • Figure 11.28: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Diabetes, 2019-2030
  • Figure 11.29: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Glaucoma, 2019-2030
  • Figure 11.30: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Age-associated Macular Degeneration, 2019-2030
  • Figure 11.31: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Retinitis Pigmentosa, 2019-2030
  • Figure 11.32: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Corneal Problems and Post-Surgical Complications, 2019-2030
  • Figure 11.33: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Others, 2019-2030
  • Figure 11.34: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific, 2019-2030
  • Figure 11.35: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Distribution by Type of Product, 2019-2030
  • Figure 11.36: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Contact Lenses, 2019-2030
  • Figure 11.37: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Therapeutic Lenses, 2019-2030
  • Figure 11.38: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Drug-Eluting Lenses, 2019-2030
  • Figure 11.39: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Diagnostic / Monitoring Contact Lenses, 2019-2030
  • Figure 11.40: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Visual Prostheses, 2019-2030
  • Figure 11.41: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Distribution by Indication, 2019-2030
  • Figure 11.42: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Diabetes, 2019-2030
  • Figure 11.43: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Glaucoma, 2019-2030
  • Figure 11.44: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Age-associated Macular Degeneration, 2019-2030
  • Figure 11.45: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Retinitis Pigmentosa, 2019-2030
  • Figure 11.46: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Corneal Problems and Post-Surgical Complications, 2019-2030
  • Figure 11.47: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Others, 2019-2030
  • Figure 13.1: Next Generation Contact Lenses: Logo Landscape of Developers across Different Regions, Type of Contact Lenses and Type of Organization
  • Figure 13.2: Overall Next Generation Contact Lenses and Visual Prostheses Market, Conservative, Base and Optimistic Scenarios, 2019, 2025 and 2030

List of Tables

  • Table 4.1: List of Next Generation Contact Lenses
  • Table 4.2: List of Therapeutic Contact Lenses
  • Table 4.3: List of Drug-Eluting Contact Lenses
  • Table 4.4: List of Diagnostic / Monitoring Contact Lenses
  • Table 4.5: List of Visual Prostheses
  • Table 5.1: ChromaGen™: Product Overview
  • Table 5.2: CUSTOMFLEX® ARTIFICIALIRIS: Product Overview
  • Table 5.3: EYEMATE®: Product Overview
  • Table 5.4: Hyper-CL™: Product Overview
  • Table 5.5: Implantable Miniature Telescope: Product Overview
  • Table 5.6: SENSIMED Triggerfish®: Product Overview
  • Table 5.7: Other Promotional Activities: Presence in Conferences
  • Table 6.1: List of Novel Technologies in Next Generation Contact Lens and Visual Prosthesis Market
  • Table 6.2: EyePrintPRO™: Technology Overview
  • Table 6.3: Interscatter Communication: Developer Overview
  • Table 6.4: Interscatter Communication: Technology Overview
  • Table 6.5: Leo Lens Technology: Developer Overview
  • Table 6.6: Leo Lens Technology: Technology Overview
  • Table 6.7: Nanowafer Technology: Developer Overview
  • Table 6.8: Nanowafer Technology: Technology Overview
  • Table 6.9: The Diamond Eye™ Technology: Developer Overview
  • Table 6.10: The Diamond Eye™ Technology: Technology Overview
  • Table 7.1: Patent Analysis: Most Popular CPC Symbols
  • Table 7.2: Patent Analysis: List of Top CPC Classifications
  • Table 7.3: Patent Analysis: Top Five CPC Classification Symbols (Johnson & Johnson Vision)
  • Table 7.4: Patent Analysis: Top Five CPC Classification Symbols (Novartis)
  • Table 7.5: Patent Analysis: Top Five CPC Classification Symbols (Allergan)
  • Table 7.6: Patent Analysis: Top Five CPC Classification Symbols (Transitions Optical)
  • Table 7.7: Patent Analysis: Top Five CPC Classification Symbols (Google)
  • Table 7.8: Patent Analysis: Top Five CPC Classification Symbols (Massachusetts General Hospital)-
  • Table 7.9: Patent Analysis: Top Five CPC Classification Symbols (University of California)
  • Table 7.10: Patent Analysis: Top Five CPC Classification Symbols (Massachusetts Institute of Technology)
  • Table 7.11: Patent Analysis: Top Five CPC Classification Symbols (University of Colorado)
  • Table 7.12: Patent Analysis: Top Five CPC Classification Symbols (University of Illinois Ophthalmology)
  • Table 7.13: Patent Analysis: Categorization based on Weighted Valuation Scores
  • Table 7.14: Patent Analysis: List of Leading Patents
  • Table 8.1: Next Generation Contact Lenses and Visual Prostheses: Partnerships and Collaborations
  • Table 10.1: KOL Analysis: List of Principal Investigators / Sub-Investigators / Study Directors
  • Table 10.2: KOL Analysis: List of Universities and Hospitals
  • Table 10.3: KOL Analysis: Scoring System
  • Table 10.4: Profile: KOL A (Wills Eye Hospital)
  • Table 10.5: Profile: KOL B (Retina Foundation of the Southwest)
  • Table 10.6: Profile: KOL C (Rabin Medical Center)
  • Table 10.7: Profile: KOL D (University of Oxford)
  • Table 10.8: Profile: KOL E (New York Eye and Ear Infirmary)
  • Table 10.9: Profile: KOL F (Fred Hutchinson Cancer Research Center)
  • Table 14.1: Next Generation Contact Lenses: Distribution by Type of Developer
  • Table 14.2: Next Generation Contact Lenses: Distribution by Type of Developer and Type of Contact Lenses
  • Table 14.3: Next Generation Contact Lenses: Distribution by Location of Headquarters of Developer
  • Table 14.4: Next Generation Contact Lenses: Distribution by Location of Headquarters of Developer and Type of Contact Lenses
  • Table 14.5: Next Generation Contact Lenses: Distribution by Status of Development
  • Table 14.6: Next Generation Contact Lenses: Distribution by Status of Development and Type of Contact Lenses
  • Table 14.7: Next Generation Contact Lenses: Distribution by Target Indication
  • Table 14.8: Next Generation Contact Lenses: Distribution by Target Indication and Type of Contact Lenses
  • Table 14.9: Next Generation Contact Lenses: Distribution by Type of Product
  • Table 14.10: Visual Prostheses: Distribution by Type of Developer
  • Table 14.11: Visual Prostheses: Distribution by Location of Headquarters of Developer
  • Table 14.12: Visual Prostheses: Distribution by Phase of Development
  • Table 14.13: Visual Prostheses: Distribution by Target Indication
  • Table 14.14: Visual Prostheses: Distribution by Implant Site
  • Table 14.15: Patent Analysis: Distribution by Type of Patent
  • Table 14.16: Patent Analysis: Cumulative Distribution by Publication Year, 2013-2018
  • Table 14.17: Patent Analysis: Distribution by Geography
  • Table 14.18: Patent Analysis: Distribution by Leading Industry Players
  • Table 14.19: Patent Analysis: Distribution by Leading Non-Industry Players
  • Table 14.20: Patent Analysis (Industry Players): Number of Patents Across Different Geographies
  • Table 14.21: Patent Analysis (Industry Players): Benchmarking by International Patents
  • Table 14.22: Patent Analysis (Non-Industry Players): Number of Patents Across Different Geographies
  • Table 14.23: Patent Analysis (Non-Industry Players): Benchmarking by International Patents
  • Table 14.24: Patent Analysis: Distribution of Patents by Age (January 2013- Mid October 2018)
  • Table 14.25: Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 14.26: Partnerships and Collaborations: Distribution by Type of Organization
  • Table 14.27: Partnerships and Collaborations: Distribution by Application Areas
  • Table 14.28: Partnerships and Collaborations: Distribution by Target Indication
  • Table 14.29: Partnerships and Collaborations: Regional Distribution
  • Table 14.30: Partnerships and Collaborations: Intercontinental and Intracontinental Distribution
  • Table 14.31: Overall Next Generation Contact Lenses and Visual Prostheses Market, 2019-2030
  • Table 14.32: Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Type of Product, 2019-2030
  • Table 14.33: Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Type of Contact Lenses, 2019-2030
  • Table 14.34: Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Type of Indications, 2019-2030
  • Table 14.35: Next Generation Contact Lenses and Visual Prostheses Market: Regional Distribution, 2019-2030
  • Table 14.36: Next Generation Contact Lenses and Visual Prostheses Market in North America, 2019-2030
  • Table 14.37: Next Generation Contact Lenses and Visual Prostheses Market in North America: Distribution by Type of Product, 2019-2030
  • Table 14.38: Next Generation Contact Lenses and Visual Prostheses Market in North America: Contact Lenses, 2019-2030
  • Table 14.39: Next Generation Contact Lenses and Visual Prostheses Market in North America: Therapeutic Lenses, 2019-2030
  • Table 14.40: Next Generation Contact Lenses and Visual Prostheses Market in North America: Drug-Eluting Lenses, 2019-2030
  • Table 14.41: Next Generation Contact Lenses and Visual Prostheses Market in North America: Diagnostic / Monitoring Lenses, 2019-2030
  • Table 14.42: Next Generation Contact Lenses and Visual Prostheses Market in North America: Visual Prostheses, 2019-2030
  • Table 14.43: Next Generation Contact Lenses and Visual Prostheses Market in North America: Distribution by Indication, 2019-2030
  • Table 14.44: Next Generation Contact Lenses and Visual Prostheses Market in North America: Diabetes, 2019-2030
  • Table 14.45: Next Generation Contact Lenses and Visual Prostheses Market in North America: Glaucoma, 2019-2030
  • Table 14.46: Next Generation Contact Lenses and Visual Prostheses Market in North America: Age-associated Macular Degeneration, 2019-2030
  • Table 14.47: Next Generation Contact Lenses and Visual Prostheses Market in North America: Retinitis Pigmentosa, 2019-2030
  • Table 14.48: Next Generation Contact Lenses and Visual Prostheses Market in North America: Corneal Problems and Post-Surgical Complications, 2019-2030
  • Table 11.49: Next Generation Contact Lenses and Visual Prostheses Market in North America: Others, 2019-2030
  • Table 14.50: Next Generation Contact Lenses and Visual Prostheses Market in EU5, 2019-2030
  • Table 14.51: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Distribution by Type of Product, 2019-2030
  • Table 14.52: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Contact Lenses, 2019-2030
  • Table 14.53: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Therapeutic Lenses, 2019-2030
  • Table 14.54: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Drug-Eluting Lenses, 2019-2030
  • Table 14.55: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Diagnostic / Monitoring Lenses, 2019-2030
  • Table 14.56: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Visual Prostheses, 2019-2030
  • Table 14.57: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Distribution by Indication, 2019-2030
  • Table 14.58: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Diabetes, 2019-2030
  • Table 14.59: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Glaucoma, 2019-2030
  • Table 14.60: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Age-associated Macular Degeneration, 2019-2030
  • Table 14.61: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Retinitis Pigmentosa, 2019-2030
  • Table 14.62: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Corneal Problems and Post-Surgical Complications, 2019-2030
  • Table 14.63: Next Generation Contact Lenses and Visual Prostheses Market in EU5: Others, 2019-2030
  • Table 14.64: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific, 2019-2030
  • Table 14.65: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Distribution by Type of Product, 2019-2030
  • Table 14.66: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Contact Lenses, 2019-2030
  • Table 14.67: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Therapeutic Lenses, 2019-2030
  • Table 14.68: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Drug-Eluting Lenses, 2019-2030
  • Table 14.69: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Diagnostic / Monitoring Contact Lenses, 2019-2030
  • Table 14.70: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Visual Prostheses, 2019-2030
  • Table 14.71: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Distribution by Indication, 2019-2030
  • Table 14.72: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Diabetes, 2019-2030
  • Table 14.73: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Glaucoma, 2019-2030
  • Table 14.74: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Age-associated Macular Degeneration, 2019-2030
  • Table 14.75: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Retinitis Pigmentosa, 2019-2030
  • Table 14.76: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Corneal Problems and Post-Surgical Complications, 2019-2030
  • Table 14.77: Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Others, 2019-2030

Listed Companies

The following companies and organizations have been mentioned in the report.

  • 1. [W] Eye Clinic
  • 2. Aachen University Hospital
  • 3. Abbott Medical Optics
  • 4. Alcon
  • 5. Alden Optical
  • 6. Alfred Hospital
  • 7. Allergan
  • 8. Applied Genetic Technologies
  • 9. Assaf Harofeh Medical Center
  • 10. Associated Eye Care
  • 11. Bascom Palmer Eye Institute
  • 12. Baylor College of Medicine
  • 13. Bionic Sight
  • 14. Bionic Vision Technologies
  • 15. Bionics Institute
  • 16. Boston Children's Hospital
  • 17. California Institute of Technology
  • 18. China Pharmaceutical University
  • 19. ChromaGen Vision
  • 20. Civil Aviation University of China
  • 21. Cleveland Clinic
  • 22. Clinic Saint Jean
  • 23. Cornea Consultants of Texas
  • 24. Dry Eye Center of Northeastern Pennsylvania
  • 25. Duke University School of Medicine
  • 26. Emory University
  • 27. Eye Associates of New Mexico
  • 28. Eye Care of San Diego
  • 29. Eye Clinic Wittenbergplatz
  • 30. Eye Physicians of Long Beach
  • 31. Eye Specialty Group
  • 32. EyeGate Pharma
  • 33. EyePrint Prosthetics
  • 34. EyeYon Medical
  • 35. Fortis Memorial Research Institute
  • 36. Fred Hutchinson Cancer Research Center
  • 37. Ghent University
  • 38. Google
  • 39. Grey Innovation
  • 40. Harvard Medical School
  • 41. Hospital Dresden-Friedrichstadt
  • 42. HumanOptics
  • 43. imec
  • 44. Implandata Ophthalmic Products
  • 45. Institute of Ocular Microsurgery
  • 46. Interojo
  • 47. Johannes Gutenberg University Mainz
  • 48. Johns Hopkins Wilmer Eye Institute
  • 49. Johnson & Johnson
  • 50. K N Toosi University of Technology
  • 51. Karlsruhe Municipal Hospital
  • 52. King's College Hospital
  • 53. Kish Healthcare Biotechnologies
  • 54. Klinikum rechts der Isar
  • 55. Knappschaftsklinikum Saar
  • 56. Korea Advanced Institute of Science and Technology
  • 57. Korea Institute of Science and Technology
  • 58. Kyungpook National University
  • 59. Leo Lens
  • 60. LG Innotek
  • 61. Loma Linda University Medical Center
  • 62. Massachusetts Eye and Ear Infirmary
  • 63. Massachusetts Institute of Technology
  • 64. Mayo Clinic
  • 65. Medella Health
  • 66. Mercy Clinic Eye Specialists
  • 67. Mid Atlantic Retina
  • 68. Minifab
  • 69. Minnesota Eye Consultants
  • 70. Monash University
  • 71. Moorfields Eye Hospital
  • 72. Nano Retina
  • 73. Nanovision Biosciences
  • 74. Nanyang Technological University
  • 75. Nara Institute of Science and Technology
  • 76. National Vision Research Institute
  • 77. New York Eye and Ear Infirmary
  • 78. NIDEK
  • 79. NJRetina
  • 80. Northwestern University
  • 81. Novartis
  • 82. OcuMedic
  • 83. OPHTEC
  • 84. Orange County Retina
  • 85. Oregon State University
  • 86. Osaka University
  • 87. PHI BioMed
  • 88. Pixium Vision
  • 89. Pohang University of Science and Technology
  • 90. Poitiers University Hospital
  • 91. Poznan University of Medical Sciences
  • 92. Purdue University
  • 93. Queen's University Belfast
  • 94. Quinze-Vingts National Ophthalmology Hospital
  • 95. Rabin Medical Center
  • 96. Retina Consultants of Hawaii
  • 97. Retina Foundation of the Southwest
  • 98. Retina Implant
  • 99. Retinal Consultants of Arizona
  • 100. Royal Victorian Eye and Ear Hospital
  • 101. Sanglah General Hospital
  • 102. Sarasota Retina Institute
  • 103. Second Sight
  • 104. SEED
  • 105. Semmelweis University
  • 106. SENSIMED
  • 107. Seoul National University
  • 108. Sight Sciences
  • 109. Sightbox
  • 110. Southeast University
  • 111. St Paul's Eye Hospital
  • 112. Stony Brook University Hospital
  • 113. Swiss Federal Institute of Technology
  • 114. The University of Hong Kong
  • 115. Transitions Optical
  • 116. Tufts University School of Medicine
  • 117. Udayana University
  • 118. Uka Tarsadia University
  • 119. Ulsan National Institute of Science and Technology
  • 120. UltraVision CLPL
  • 121. University Hospital of Würzburg
  • 122. University Health Network
  • 123. University Hospital Center of Bordeaux
  • 124. University Hospital Leipzig
  • 125. University Hospital Tuebingen
  • 126. University Hospital Zurich
  • 127. University Medical Center Hamburg-Eppendorf
  • 128. University Medical Center Schleswig-Holstein
  • 129. University of Bern
  • 130. University of Birmingham
  • 131. University of California
  • 132. University of Cologne
  • 133. University of Colorado
  • 134. University of Florida
  • 135. University of Houston
  • 136. University of Illinois
  • 137. University of Liverpool
  • 138. University of Maryland
  • 139. University of Melbourne
  • 140. University of Michigan Kellogg Eye Center
  • 141. University of Minnesota
  • 142. University of North Carolina
  • 143. University of Oxford
  • 144. University of Pittsburgh Medical Center
  • 145. University of Sydney
  • 146. University of Texas
  • 147. University of Washington
  • 148. University of Waterloo
  • 149. Verily Life Sciences
  • 150. Veristat
  • 151. VisionCare Ophthalmic Technologies
  • 152. Wenzhou Medical College
Back to Top